{"id": "236537", "url": "https://fevir.net/resources/Composition/236537", "date": "2025-10-21T14:50:13.423Z", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/summary-of-findings"], "versionId": "78", "lastUpdated": "2025-10-21T14:50:13.423Z"}, "type": {"text": "Summary of Findings", "coding": [{"code": "SummaryOfFindings", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "SummaryOfFindings"}]}, "title": "SummaryOfFindings: GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "author": [{"display": "Qiukui Hao"}], "status": "final", "custodian": {"type": "Organization", "display": "Computable Publishing LLC", "reference": "Organization/118079"}, "relatesTo": [{"type": "part-of", "targetReference": {"type": "Composition", "display": "MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-conversion-report", "assigner": {"display": "Computable Publishing LLC"}}}}, {"type": "part-of", "targetReference": {"type": "Composition", "display": "ComparativeEvidenceSynthesisReport: GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Composition/236538", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-comparative-evidence-report-85390-85789", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}}, {"type": "cite-as", "targetMarkdown": "SummaryOfFindings: GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk [Database Entry: FHIR Composition Resource]. Contributors: Qiukui Hao [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236537. Revised 2025-10-21. Available at: https://fevir.net/resources/Composition/236537. Computable resource at: https://fevir.net/resources/Composition/236537#json."}], "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"code": "ACSN", "system": "http://terminology.hl7.org/CodeSystem/v2-0203", "display": "Accession ID"}]}, "value": "236537", "system": "https://fevir.net/FOI", "assigner": {"display": "Computable Publishing LLC"}}, {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-summary-of-findings-85390-85789", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}], "resourceType": "Composition", "section": [{"code": {"coding": [{"code": "column-headers", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Column Headers"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No narrative text.]</p></div>", "status": "empty"}, "title": "Column Headers", "section": [{"code": {"coding": [{"code": "outcome-measure", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Outcome Measure"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Outcome</p></div>", "status": "generated"}, "title": "Outcome Measure"}, {"code": {"coding": [{"code": "sample-size", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Sample Size"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Sample Size</p></div>", "status": "generated"}, "title": "Sample Size"}, {"code": {"coding": [{"code": "result-with-comparator-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with comparator alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Result Without Treatment</p></div>", "status": "generated"}, "title": "Result Without Treatment"}, {"code": {"coding": [{"code": "result-with-intervention-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Result With Treatment (Observed)</p></div>", "status": "generated"}, "title": "Result With Treatment--Observed"}, {"code": {"text": "result with intervention with calculated value derived from the control group and effect estimate", "coding": [{"code": "result-with-intervention-alone-calculated", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone (calculated)"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Result With Treatment (Calculated)</p></div>", "status": "generated"}, "title": "Result With Treatment--Derived"}, {"code": {"coding": [{"code": "result-with-intervention-vs-comparator", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention vs. comparator"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Effect Estimate</p></div>", "status": "generated"}, "title": "Effect Estimate"}, {"code": {"coding": [{"code": "certainty-of-evidence", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Certainty of Evidence"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Certainty of Evidence</p></div>", "status": "generated"}, "title": "Certainty of Evidence"}, {"code": {"coding": [{"code": "assertion", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Assertion"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>What this means</p></div>", "status": "generated"}, "title": "Assertion"}]}, {"code": {"coding": [{"code": "summary-of-findings", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Summary of Findings"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>", "status": "empty"}, "title": "Summary of Findings", "section": [{"code": {"coding": [{"code": "summary-of-findings-entry-for-a-single-outcome", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"type": "EvidenceVariable", "display": "OutcomeDefinition: All-cause mortality", "reference": "EvidenceVariable/236539", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-313876", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}, "title": "All-cause mortality", "section": [{"code": {"coding": [{"code": "outcome-measure", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Outcome Measure"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>OutcomeDefinition: All-cause mortality</p></div>", "status": "generated"}, "entry": [{"type": "EvidenceVariable", "display": "OutcomeDefinition: All-cause mortality", "reference": "EvidenceVariable/236539", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-313876", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Outcome"}, {"code": {"coding": [{"code": "sample-size", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Sample Size"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>34 studies, 69035 participants</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: All-cause mortality with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236540", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313876-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Sample Size"}, {"code": {"coding": [{"code": "result-with-comparator-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with comparator alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>12%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived ComparatorOnlyEvidence: All-cause mortality in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236541", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313876-comparator-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result Without Treatment"}, {"code": {"coding": [{"code": "result-with-intervention-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>10.7%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived InterventionOnlyEvidence: All-cause mortality in GLP-1 RA Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/293872", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313876-intervention-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result With Treatment--Observed"}, {"code": {"text": "result with intervention with calculated value derived from the control group and effect estimate", "coding": [{"code": "result-with-intervention-alone-calculated", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone (calculated)"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>10.71%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived ComparatorOnlyEvidence: All-cause mortality in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236541", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313876-comparator-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}, {"type": "Evidence", "display": "MAGIC-derived Evidence: All-cause mortality with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236540", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313876-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result With Treatment--Derived"}, {"code": {"coding": [{"code": "result-with-intervention-vs-comparator", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention vs. comparator"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>-1.29% (-1.83% to -0.64%)</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: All-cause mortality with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236540", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313876-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Effect Estimate"}, {"code": {"coding": [{"code": "certainty-of-evidence", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Certainty of Evidence"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Moderate certainty -- Due to serious imprecision</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: All-cause mortality with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236540", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313876-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Certainty of Evidence"}, {"code": {"coding": [{"code": "assertion", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Assertion"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>GLP-1 receptor agonists probably reduce the risk of death compared with standard care.</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: All-cause mortality with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236540", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313876-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Assertion"}]}, {"code": {"coding": [{"code": "summary-of-findings-entry-for-a-single-outcome", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"type": "EvidenceVariable", "display": "OutcomeDefinition: Cardiovascular mortality", "reference": "EvidenceVariable/236542", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-313877", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}, "title": "Cardiovascular mortality", "section": [{"code": {"coding": [{"code": "outcome-measure", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Outcome Measure"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>OutcomeDefinition: Cardiovascular mortality</p></div>", "status": "generated"}, "entry": [{"type": "EvidenceVariable", "display": "OutcomeDefinition: Cardiovascular mortality", "reference": "EvidenceVariable/236542", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-313877", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Outcome"}, {"code": {"coding": [{"code": "sample-size", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Sample Size"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>20 studies, 63455 participants</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Cardiovascular mortality with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236543", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313877-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Sample Size"}, {"code": {"coding": [{"code": "result-with-comparator-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with comparator alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>7.9%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived ComparatorOnlyEvidence: Cardiovascular mortality in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236544", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313877-comparator-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result Without Treatment"}, {"code": {"coding": [{"code": "result-with-intervention-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>7%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived InterventionOnlyEvidence: Cardiovascular mortality in GLP-1 RA Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/293873", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313877-intervention-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result With Treatment--Observed"}, {"code": {"text": "result with intervention with calculated value derived from the control group and effect estimate", "coding": [{"code": "result-with-intervention-alone-calculated", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone (calculated)"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>7.02%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived ComparatorOnlyEvidence: Cardiovascular mortality in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236544", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313877-comparator-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}, {"type": "Evidence", "display": "MAGIC-derived Evidence: Cardiovascular mortality with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236543", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313877-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result With Treatment--Derived"}, {"code": {"coding": [{"code": "result-with-intervention-vs-comparator", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention vs. comparator"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>-0.88% (-1.48% to -0.29%)</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Cardiovascular mortality with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236543", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313877-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Effect Estimate"}, {"code": {"coding": [{"code": "certainty-of-evidence", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Certainty of Evidence"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Moderate certainty -- Due to serious imprecision</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Cardiovascular mortality with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236543", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313877-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Certainty of Evidence"}, {"code": {"coding": [{"code": "assertion", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Assertion"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>GLP-1 receptor agonists probably reduce the risk of cardiovascular death compared with standard care.</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Cardiovascular mortality with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236543", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313877-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Assertion"}]}, {"code": {"coding": [{"code": "summary-of-findings-entry-for-a-single-outcome", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"type": "EvidenceVariable", "display": "OutcomeDefinition: Nonfatal myocardial infarction", "reference": "EvidenceVariable/236545", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-313878", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}, "title": "Nonfatal myocardial infarction", "section": [{"code": {"coding": [{"code": "outcome-measure", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Outcome Measure"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>OutcomeDefinition: Nonfatal myocardial infarction</p></div>", "status": "generated"}, "entry": [{"type": "EvidenceVariable", "display": "OutcomeDefinition: Nonfatal myocardial infarction", "reference": "EvidenceVariable/236545", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-313878", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Outcome"}, {"code": {"coding": [{"code": "sample-size", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Sample Size"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>32 studies, 67956 participants</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Nonfatal myocardial infarction with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236546", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313878-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Sample Size"}, {"code": {"coding": [{"code": "result-with-comparator-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with comparator alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>10.8%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived ComparatorOnlyEvidence: Nonfatal myocardial infarction in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236547", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313878-comparator-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result Without Treatment"}, {"code": {"coding": [{"code": "result-with-intervention-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>10%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived InterventionOnlyEvidence: Nonfatal myocardial infarction in GLP-1 RA Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/293874", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313878-intervention-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result With Treatment--Observed"}, {"code": {"text": "result with intervention with calculated value derived from the control group and effect estimate", "coding": [{"code": "result-with-intervention-alone-calculated", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone (calculated)"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>10.02%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived ComparatorOnlyEvidence: Nonfatal myocardial infarction in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236547", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313878-comparator-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}, {"type": "Evidence", "display": "MAGIC-derived Evidence: Nonfatal myocardial infarction with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236546", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313878-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result With Treatment--Derived"}, {"code": {"coding": [{"code": "result-with-intervention-vs-comparator", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention vs. comparator"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>-0.78% (-1.47% to -0.1%)</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Nonfatal myocardial infarction with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236546", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313878-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Effect Estimate"}, {"code": {"coding": [{"code": "certainty-of-evidence", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Certainty of Evidence"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Moderate certainty -- Due to serious imprecision</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Nonfatal myocardial infarction with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236546", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313878-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Certainty of Evidence"}, {"code": {"coding": [{"code": "assertion", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Assertion"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>GLP-1 receptor agonists probably reduce the risk of nonfatal myocardial infarction compared with standard care.</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Nonfatal myocardial infarction with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236546", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313878-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Assertion"}]}, {"code": {"coding": [{"code": "summary-of-findings-entry-for-a-single-outcome", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"type": "EvidenceVariable", "display": "OutcomeDefinition: Nonfatal stroke", "reference": "EvidenceVariable/236548", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-313879", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}, "title": "Nonfatal stroke", "section": [{"code": {"coding": [{"code": "outcome-measure", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Outcome Measure"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>OutcomeDefinition: Nonfatal stroke</p></div>", "status": "generated"}, "entry": [{"type": "EvidenceVariable", "display": "OutcomeDefinition: Nonfatal stroke", "reference": "EvidenceVariable/236548", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-313879", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Outcome"}, {"code": {"coding": [{"code": "sample-size", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Sample Size"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>29 studies, 66900 participants</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Nonfatal stroke with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236549", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313879-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Sample Size"}, {"code": {"coding": [{"code": "result-with-comparator-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with comparator alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>10.8%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived ComparatorOnlyEvidence: Nonfatal stroke in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236550", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313879-comparator-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result Without Treatment"}, {"code": {"coding": [{"code": "result-with-intervention-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>9.2%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived InterventionOnlyEvidence: Nonfatal stroke in GLP-1 RA Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/293875", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313879-intervention-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result With Treatment--Observed"}, {"code": {"text": "result with intervention with calculated value derived from the control group and effect estimate", "coding": [{"code": "result-with-intervention-alone-calculated", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone (calculated)"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>9.23%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived ComparatorOnlyEvidence: Nonfatal stroke in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236550", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313879-comparator-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}, {"type": "Evidence", "display": "MAGIC-derived Evidence: Nonfatal stroke with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236549", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313879-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result With Treatment--Derived"}, {"code": {"coding": [{"code": "result-with-intervention-vs-comparator", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention vs. comparator"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>-1.57% (-2.37% to -0.68%)</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Nonfatal stroke with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236549", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313879-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Effect Estimate"}, {"code": {"coding": [{"code": "certainty-of-evidence", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Certainty of Evidence"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Moderate certainty -- Due to serious imprecision</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Nonfatal stroke with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236549", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313879-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Certainty of Evidence"}, {"code": {"coding": [{"code": "assertion", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Assertion"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>GLP-1 receptor agonists probably reduce the risk of nonfatal stroke compared with standard care.</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Nonfatal stroke with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236549", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313879-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Assertion"}]}, {"code": {"coding": [{"code": "summary-of-findings-entry-for-a-single-outcome", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"type": "EvidenceVariable", "display": "OutcomeDefinition: End-stage kidney disease", "reference": "EvidenceVariable/236551", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-313880", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}, "title": "End-stage kidney disease", "section": [{"code": {"coding": [{"code": "outcome-measure", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Outcome Measure"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>OutcomeDefinition: End-stage kidney disease</p></div>", "status": "generated"}, "entry": [{"type": "EvidenceVariable", "display": "OutcomeDefinition: End-stage kidney disease", "reference": "EvidenceVariable/236551", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-313880", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Outcome"}, {"code": {"coding": [{"code": "sample-size", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Sample Size"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>4 studies, 10762 participants</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: End-stage kidney disease with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236552", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313880-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Sample Size"}, {"code": {"coding": [{"code": "result-with-comparator-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with comparator alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>2%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived ComparatorOnlyEvidence: End-stage kidney disease in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236553", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313880-comparator-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result Without Treatment"}, {"code": {"coding": [{"code": "result-with-intervention-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>1.6%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived InterventionOnlyEvidence: End-stage kidney disease in GLP-1 RA Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/293876", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313880-intervention-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result With Treatment--Observed"}, {"code": {"text": "result with intervention with calculated value derived from the control group and effect estimate", "coding": [{"code": "result-with-intervention-alone-calculated", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone (calculated)"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>1.57%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived ComparatorOnlyEvidence: End-stage kidney disease in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236553", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313880-comparator-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}, {"type": "Evidence", "display": "MAGIC-derived Evidence: End-stage kidney disease with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236552", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313880-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result With Treatment--Derived"}, {"code": {"coding": [{"code": "result-with-intervention-vs-comparator", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention vs. comparator"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>-0.43% (-0.65% to -0.16%)</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: End-stage kidney disease with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236552", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313880-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Effect Estimate"}, {"code": {"coding": [{"code": "certainty-of-evidence", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Certainty of Evidence"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>High certainty</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: End-stage kidney disease with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236552", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313880-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Certainty of Evidence"}, {"code": {"coding": [{"code": "assertion", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Assertion"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>There is no important difference between GLP-1 receptor agonists and standard care.</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: End-stage kidney disease with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236552", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313880-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Assertion"}]}, {"code": {"coding": [{"code": "summary-of-findings-entry-for-a-single-outcome", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"type": "EvidenceVariable", "display": "OutcomeDefinition: Heart failure", "reference": "EvidenceVariable/236554", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-313881", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}, "title": "Heart failure", "section": [{"code": {"coding": [{"code": "outcome-measure", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Outcome Measure"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>OutcomeDefinition: Heart failure</p></div>", "status": "generated"}, "entry": [{"type": "EvidenceVariable", "display": "OutcomeDefinition: Heart failure", "reference": "EvidenceVariable/236554", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-313881", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Outcome"}, {"code": {"coding": [{"code": "sample-size", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Sample Size"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>13 studies, 46696 participants</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Heart failure with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236555", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313881-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Sample Size"}, {"code": {"coding": [{"code": "result-with-comparator-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with comparator alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>8%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived ComparatorOnlyEvidence: Heart failure in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236556", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313881-comparator-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result Without Treatment"}, {"code": {"coding": [{"code": "result-with-intervention-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>7.6%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived InterventionOnlyEvidence: Heart failure in GLP-1 RA Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/293877", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313881-intervention-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result With Treatment--Observed"}, {"code": {"text": "result with intervention with calculated value derived from the control group and effect estimate", "coding": [{"code": "result-with-intervention-alone-calculated", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone (calculated)"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>7.56%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived ComparatorOnlyEvidence: Heart failure in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236556", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313881-comparator-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}, {"type": "Evidence", "display": "MAGIC-derived Evidence: Heart failure with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236555", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313881-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result With Treatment--Derived"}, {"code": {"coding": [{"code": "result-with-intervention-vs-comparator", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention vs. comparator"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>-0.44% (-1.12% to 0.22%)</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Heart failure with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236555", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313881-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Effect Estimate"}, {"code": {"coding": [{"code": "certainty-of-evidence", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Certainty of Evidence"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Moderate certainty -- Due to serious imprecision</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Heart failure with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236555", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313881-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Certainty of Evidence"}, {"code": {"coding": [{"code": "assertion", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Assertion"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>GLP-1 receptor agonists probably reduce the risk of heart failure compared with standard care.</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Heart failure with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236555", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313881-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Assertion"}]}, {"code": {"coding": [{"code": "summary-of-findings-entry-for-a-single-outcome", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"type": "EvidenceVariable", "display": "OutcomeDefinition: Serious hyperglycaemia", "reference": "EvidenceVariable/236557", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-313882", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}, "title": "Serious hyperglycaemia", "section": [{"code": {"coding": [{"code": "outcome-measure", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Outcome Measure"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>OutcomeDefinition: Serious hyperglycaemia</p></div>", "status": "generated"}, "entry": [{"type": "EvidenceVariable", "display": "OutcomeDefinition: Serious hyperglycaemia", "reference": "EvidenceVariable/236557", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-313882", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Outcome"}, {"code": {"coding": [{"code": "sample-size", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Sample Size"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>12 studies, 30066 participants</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Serious hyperglycaemia with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236558", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313882-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Sample Size"}, {"code": {"coding": [{"code": "result-with-comparator-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with comparator alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>2.5%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived ComparatorOnlyEvidence: Serious hyperglycaemia in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236559", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313882-comparator-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result Without Treatment"}, {"code": {"coding": [{"code": "result-with-intervention-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>1%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived InterventionOnlyEvidence: Serious hyperglycaemia in GLP-1 RA Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/293878", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313882-intervention-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result With Treatment--Observed"}, {"code": {"text": "result with intervention with calculated value derived from the control group and effect estimate", "coding": [{"code": "result-with-intervention-alone-calculated", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone (calculated)"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>1.02%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived ComparatorOnlyEvidence: Serious hyperglycaemia in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236559", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313882-comparator-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}, {"type": "Evidence", "display": "MAGIC-derived Evidence: Serious hyperglycaemia with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236558", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313882-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result With Treatment--Derived"}, {"code": {"coding": [{"code": "result-with-intervention-vs-comparator", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention vs. comparator"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>-1.48% (-1.86% to -0.89%)</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Serious hyperglycaemia with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236558", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313882-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Effect Estimate"}, {"code": {"coding": [{"code": "certainty-of-evidence", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Certainty of Evidence"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>High certainty</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Serious hyperglycaemia with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236558", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313882-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Certainty of Evidence"}, {"code": {"coding": [{"code": "assertion", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Assertion"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>GLP-1 receptor agonists reduce the risk of serious hyperglycaemia compared with standard care.</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Serious hyperglycaemia with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236558", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313882-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Assertion"}]}, {"code": {"coding": [{"code": "summary-of-findings-entry-for-a-single-outcome", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"type": "EvidenceVariable", "display": "OutcomeDefinition: Severe gastrointestinal events", "reference": "EvidenceVariable/236560", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-313883", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}, "title": "Severe gastrointestinal events", "section": [{"code": {"coding": [{"code": "outcome-measure", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Outcome Measure"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>OutcomeDefinition: Severe gastrointestinal events</p></div>", "status": "generated"}, "entry": [{"type": "EvidenceVariable", "display": "OutcomeDefinition: Severe gastrointestinal events", "reference": "EvidenceVariable/236560", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-313883", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Outcome"}, {"code": {"coding": [{"code": "sample-size", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Sample Size"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>7 studies, 24638 participants</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Severe gastrointestinal events with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236561", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313883-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Sample Size"}, {"code": {"coding": [{"code": "result-with-comparator-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with comparator alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>4.4%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived ComparatorOnlyEvidence: Severe gastrointestinal events in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236562", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313883-comparator-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result Without Treatment"}, {"code": {"coding": [{"code": "result-with-intervention-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>10.2%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived InterventionOnlyEvidence: Severe gastrointestinal events in GLP-1 RA Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/293879", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313883-intervention-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result With Treatment--Observed"}, {"code": {"text": "result with intervention with calculated value derived from the control group and effect estimate", "coding": [{"code": "result-with-intervention-alone-calculated", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone (calculated)"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>10.17%</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived ComparatorOnlyEvidence: Severe gastrointestinal events in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236562", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313883-comparator-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}, {"type": "Evidence", "display": "MAGIC-derived Evidence: Severe gastrointestinal events with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236561", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313883-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result With Treatment--Derived"}, {"code": {"coding": [{"code": "result-with-intervention-vs-comparator", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention vs. comparator"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>5.77% (0.92% to 14.22%)</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Severe gastrointestinal events with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236561", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313883-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Effect Estimate"}, {"code": {"coding": [{"code": "certainty-of-evidence", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Certainty of Evidence"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Low certainty -- Due to inconsistency and serious imprecision.</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Severe gastrointestinal events with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236561", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313883-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Certainty of Evidence"}, {"code": {"coding": [{"code": "assertion", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Assertion"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>GLP-1 receptor agonists may increase the risk of severe gastrointestinal events compared with standard care.</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Severe gastrointestinal events with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236561", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313883-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Assertion"}]}, {"code": {"coding": [{"code": "summary-of-findings-entry-for-a-single-outcome", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"type": "EvidenceVariable", "display": "OutcomeDefinition: Health-related quality of life", "reference": "EvidenceVariable/236563", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-109569", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}, "title": "Health-related quality of life", "section": [{"code": {"coding": [{"code": "outcome-measure", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Outcome Measure"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>OutcomeDefinition: Health-related quality of life</p></div>", "status": "generated"}, "entry": [{"type": "EvidenceVariable", "display": "OutcomeDefinition: Health-related quality of life", "reference": "EvidenceVariable/236563", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-109569", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Outcome"}, {"code": {"coding": [{"code": "sample-size", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Sample Size"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No sample size data.]</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Health-related quality of life with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236564", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109569-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Sample Size"}, {"code": {"coding": [{"code": "result-with-comparator-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with comparator alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a proportion.]</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived ComparatorOnlyEvidence: Health-related quality of life in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236565", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109569-comparator-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result Without Treatment"}, {"code": {"coding": [{"code": "result-with-intervention-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a proportion.]</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived InterventionOnlyEvidence: Health-related quality of life in GLP-1 RA Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/293880", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109569-intervention-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result With Treatment--Observed"}, {"code": {"text": "result with intervention with calculated value derived from the control group and effect estimate", "coding": [{"code": "result-with-intervention-alone-calculated", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone (calculated)"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a proportion.]</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived ComparatorOnlyEvidence: Health-related quality of life in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236565", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109569-comparator-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}, {"type": "Evidence", "display": "MAGIC-derived Evidence: Health-related quality of life with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236564", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109569-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result With Treatment--Derived"}, {"code": {"coding": [{"code": "result-with-intervention-vs-comparator", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention vs. comparator"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a difference in proportions.]</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Health-related quality of life with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236564", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109569-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Effect Estimate"}, {"code": {"coding": [{"code": "certainty-of-evidence", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Certainty of Evidence"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Low certainty -- Due to very serious imprecision</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Health-related quality of life with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236564", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109569-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Certainty of Evidence"}, {"code": {"coding": [{"code": "assertion", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Assertion"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>GLP-1 receptor agonists may have little or no impact on health-related quality of life.</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Health-related quality of life with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236564", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109569-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Assertion"}]}, {"code": {"coding": [{"code": "summary-of-findings-entry-for-a-single-outcome", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"type": "EvidenceVariable", "display": "OutcomeDefinition: Body weight", "reference": "EvidenceVariable/236566", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-109570", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}, "title": "Body weight", "section": [{"code": {"coding": [{"code": "outcome-measure", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Outcome Measure"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>OutcomeDefinition: Body weight</p></div>", "status": "generated"}, "entry": [{"type": "EvidenceVariable", "display": "OutcomeDefinition: Body weight", "reference": "EvidenceVariable/236566", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-109570", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Outcome"}, {"code": {"coding": [{"code": "sample-size", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Sample Size"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>60 studies, 44432 participants</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Body weight with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236567", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109570-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Sample Size"}, {"code": {"coding": [{"code": "result-with-comparator-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with comparator alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a proportion.]</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived ComparatorOnlyEvidence: Body weight in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236568", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109570-comparator-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result Without Treatment"}, {"code": {"coding": [{"code": "result-with-intervention-alone", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a proportion.]</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived InterventionOnlyEvidence: Body weight in GLP-1 RA Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/293881", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109570-intervention-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result With Treatment--Observed"}, {"code": {"text": "result with intervention with calculated value derived from the control group and effect estimate", "coding": [{"code": "result-with-intervention-alone-calculated", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention alone (calculated)"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a proportion.]</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived ComparatorOnlyEvidence: Body weight in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236568", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109570-comparator-only-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}, {"type": "Evidence", "display": "MAGIC-derived Evidence: Body weight with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236567", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109570-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Result With Treatment--Derived"}, {"code": {"coding": [{"code": "result-with-intervention-vs-comparator", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Result with intervention vs. comparator"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a difference in proportions.]</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Body weight with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236567", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109570-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Effect Estimate"}, {"code": {"coding": [{"code": "certainty-of-evidence", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Certainty of Evidence"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Low certainty -- Due to very serious inconsistency</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Body weight with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236567", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109570-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Certainty of Evidence"}, {"code": {"coding": [{"code": "assertion", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Assertion"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>GLP-1 receptor agonists may reduce body weight compared with standard care.</p></div>", "status": "generated"}, "entry": [{"type": "Evidence", "display": "MAGIC-derived Evidence: Body weight with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236567", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109570-comparative-evidence", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}], "title": "Assertion"}]}]}]}